For the year ending 2025-12-31, ATYR made $190K in revenue. -$74,118K in net income. Net profit margin of -39009.47%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 190 | |||
| Research and development | 60,219 | |||
| General and administrative | 17,598 | |||
| Total operating expenses | 77,817 | |||
| Loss from operations | -77,627 | |||
| Total other income (expense), net | 3,504 | |||
| Consolidated net loss | -74,123 | |||
| Net loss (gain) attributable to noncontrolling interest in pangu biopharma limited | -5 | |||
| Net loss attributable to atyr pharma, inc | -74,118 | |||
| Basic EPS | -0.8 | |||
| Diluted EPS | -0.8 | |||
| Basic Average Shares | 92,985,359 | |||
| Diluted Average Shares | 92,985,359 | |||
aTYR PHARMA INC (ATYR)
aTYR PHARMA INC (ATYR)